Axa’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-326,356
Closed -$5.18M 1041
2025
Q2
$5.18M Buy
326,356
+34,161
+12% +$511K 0.01% 556
2025
Q1
$4.37M Buy
292,195
+7,160
+3% +$127K 0.01% 578
2024
Q4
$5.41M Buy
+285,035
New +$6.03M 0.02% 524
2023
Q4
Sell
-34,729
Closed -$1.19M 1141
2023
Q3
$1.19M Sell
34,729
-6,588
-16% -$251K ﹤0.01% 809
2023
Q2
$1.65M Sell
41,317
-6,333
-13% -$252K 0.01% 760
2023
Q1
$1.87M Buy
+47,650
New +$1.75M 0.01% 781
2022
Q3
Sell
-42,221
Closed -$1.51M 1219
2022
Q2
$1.51M Sell
42,221
-25,286
-37% -$1.02M 0.01% 815
2022
Q1
$3.32M Sell
67,507
-281,600
-81% -$14.9M 0.01% 746
2021
Q4
$19.5M Sell
349,107
-32,109
-8% -$1.77M 0.05% 361
2021
Q3
$22.1M Buy
381,216
+88,447
+30% +$5.45M 0.06% 318
2021
Q2
$18.5M Sell
292,769
-3,392
-1% -$223K 0.05% 369
2021
Q1
$18.9M Buy
296,161
+92,889
+46% +$5.39M 0.06% 359
2020
Q4
$10.6M Buy
203,272
+170,294
+516% +$8.4M 0.03% 506
2020
Q3
$1.44M Sell
32,978
-674,239
-95% -$29.8M 0.01% 875
2020
Q2
$31.2M Buy
707,217
+16,631
+2% +$703K 0.12% 198
2020
Q1
$26.8M Buy
690,586
+6,572
+1% +$335K 0.13% 182
2019
Q4
$38.7M Buy
684,014
+46,055
+7% +$2.57M 0.16% 161
2019
Q3
$34M Buy
637,959
+630,101
+8,019% +$33.8M 0.14% 199
2019
Q2
$459K Buy
+7,858
New +$422K ﹤0.01% 1093
2016
Q3
Sell
-393,302
Closed -$24.4M 1360
2016
Q2
$24.4M Buy
+393,302
New +$24.2M 0.11% 235
2015
Q4
Sell
-12,289
Closed -$621K 1503
2015
Q3
$621K Sell
12,289
-500
-4% -$26.6K ﹤0.01% 1008
2015
Q2
$659K Buy
12,789
+498
+4% +$25.8K ﹤0.01% 1026
2015
Q1
$625K Buy
12,291
+6
+0% +$309 ﹤0.01% 1047
2014
Q4
$654K Buy
12,285
+8
+0.1% +$407 ﹤0.01% 1057
2014
Q3
$560K Hold
12,277
﹤0.01% 1038
2014
Q2
$581K Buy
12,277
+5
+0% +$233 ﹤0.01% 1033
2014
Q1
$565K Hold
12,272
﹤0.01% 1044
2013
Q4
$595K Buy
12,272
+1,354
+12% +$63.4K ﹤0.01% 1025
2013
Q3
$474K Buy
+10,918
New +$466K ﹤0.01% 1011

Other funds holding XRAY

Axa's XRAY Position: Q3 2025 in Review

Axa sold out of Dentsply Sirona (XRAY) in Q3 2025, closing a stake of 326,356 shares — an estimated $5.18M sold.

Axa first reported a position in XRAY in Q3 2013 and held it in 29 quarters. The position peaked at $38.7M in Q4 2019. 411 funds tracked by Wall St. Rank hold XRAY as of Q3 2025.

  • Axa reported no remaining Dentsply Sirona position as of Q3 2025 after selling out during the quarter.
  • Axa sold 326,356 Dentsply Sirona shares in Q3 2025, an estimated $5.18M.
  • Axa first reported a position in Dentsply Sirona in Q3 2013 and held it in 29 quarters.
  • Axa's Dentsply Sirona position peaked at $38.7M in Q4 2019.
  • 411 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.